StockData
Abbott Laboratories logo

Abbott Laboratories (ABT) operating KPIs

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)

Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%

Abbott Laboratories accumulated Depreciation ($M) ($M)

Form 10-K / 10-Q Balance Sheet & Footnote

Latest, FY2025
13,406
Period ended Dec 31, 2025
Change on a year earlier
+11.0%
12,082 in FY2024
History
13 years
Since FY2013
Sources
13
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAccumulated Depreciation ($M) ($M)Year on yearSource
FY2025Dec 31, 202513,406+11.0%SEC Filing (0001628280-26-050134) ↗
FY2024Dec 31, 202412,082+2.6%SEC Filing (0001628280-26-010185) ↗
FY2023Dec 31, 202311,779+6.6%SEC Filing (0001628280-25-007110) ↗
FY2022Dec 31, 202211,050+6.2%SEC Filing (0001628280-24-005348) ↗
FY2021Dec 31, 202110,405+6.6%SEC Filing (0001628280-23-004026) ↗
FY2020Dec 31, 20209,764+11.4%SEC Filing (0001104659-22-025141) ↗
FY2019Dec 31, 20198,761+7.6%SEC Filing (0001104659-21-025751) ↗
FY2018Dec 31, 20188,143+6.3%SEC Filing (0001104659-20-023904) ↗
FY2017Dec 31, 20177,658+15.0%SEC Filing (0001047469-19-000624) ↗
FY2016Dec 31, 20166,661+0.1%SEC Filing (0001047469-18-000856) ↗
FY2015Dec 31, 20156,653-0.7%SEC Filing (0001047469-17-000744) ↗
FY2014Dec 31, 20146,697-3.8%SEC Filing (0001047469-16-010246) ↗
FY2013Dec 31, 20136,965–SEC Filing (0001047469-15-001377) ↗

Cite this data

StockData. (2026). Abbott Laboratories Accumulated Depreciation ($M) ($M), annual FY2013–FY2025 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/xbrl-ppe-depr

See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.